Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 02, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Ticagrelor Tablets, 90 mg and Tentative Approval for Ticagrelor Tablets, 60 mg".